PBS Calendars
Page last updated: 21 February 2024
PBS related activities surrounding the PBAC meeting cycles
- Summary of deadlines for 2023-25 PBS monthly listing and pricing process (PDF 118KB) - (Word 17KB)
- PBAC Cycle Timeframe for 2024 - 2025
- Pre-submission meetings
Sponsors who are concerned they cannot meet the deadline to list a new brand that will trigger a first new brand price reduction, are encouraged to email PBSPricing@health.gov.au to discuss available options.
If you are considering applying to have a drug listed on the PBS, it is recommended
that you contact the Office of Health Technology Assessment (OHTA) to discuss the
listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison
Officer will be able to assist.
All contact details are available from the PBS contacts page.
PBAC Cycle Timeframe for 2024 - 2025
PBAC Cycle Timeframe for 2024 - 2025 (PDF 434KB) - (Word 55KB)
|
MEETING |
2023/3 |
2024/1 13-15 March |
2024/2 10-12 July |
2024/3 |
2025/1 |
2025/2 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Activity |
Wk |
Date |
Wk |
Date |
Wk |
Date |
Wk |
Date |
Wk |
Date |
Wk |
|
|||
|
Deadline for Notice of Intent for integrated co-dependent submissions (Wednesday 5pm AEST) |
-8 |
10 May 2023 |
-8 |
6 Sep 2023 |
-8 |
17 Jan 2024 |
-8 |
15 May 2024 |
-8 |
11 Sep 2024 |
-8 |
15 Jan 2025 |
|||
|
|
-7 |
|
-7 |
|
-7 |
|
-7 |
|
-7 |
|
-7 |
|
|||
|
|
-6 |
|
-6 |
|
-6 |
|
-6 |
|
-6 |
|
-6 |
|
|||
|
|
-5 |
|
-5 |
|
-5 |
|
-5 |
|
-5 |
|
-5 |
|
|||
|
Deadline for Notice of Intent for Category 1-4 and Committee Secretariat submissions
and Standard Re-entry resubmissions (Wednesday 5pm AEST); and Deadline for integrated co-dependent submissions (Wednesday 5pm AEST) |
-4 |
7 Jun 2023 |
-4 |
4 Oct 2023 |
-4 |
14 Feb 2024 |
-4 |
12 Jun 2024 |
-4 |
9 Oct 2024 |
-4 |
12 Feb 2025 |
|||
|
|
-3 |
|
-3 |
|
-3 |
|
-3 |
|
-3 |
|
-3 |
|
|||
|
|
-2 |
|
-2 |
|
-2 |
|
-2 |
|
-2 |
|
-2 |
|
|||
|
|
-1 |
|
-1 |
|
-1 |
|
-1 |
|
-1 |
|
-1 |
|
|||
|
Deadline for Category 1 to 4 and Committee Secretariat submissions; and
|
0 |
5 Jul 2023 |
0 |
1 Nov 2023 |
0 |
13 Mar 2024 |
0 |
10 Jul 2024 |
0 |
6 Nov 2024 |
0 |
12 Mar 2025 |
|||
|
|
1 |
|
1 |
|
1 |
|
1 |
|
1 |
|
1 |
|
|||
|
|
2 |
|
2 |
|
2 |
|
2 |
|
2 |
|
2 |
|
|||
|
Publication of the main Agenda on web (Wednesday); and
Consumer Comments open (Wednesday) |
3 |
26 Jul 2023 |
3 |
22 Nov 2023 |
3 |
3 Apr 2024 |
3 |
31 Jul 2024 |
3 |
27 Nov 2024 |
3 |
2 Apr 2025 |
|||
|
|
4 |
|
4 |
|
4 |
|
4 |
|
4 |
|
4 |
|
|||
|
Deadline for pre-submission meeting requests to meet 8 week cut-off |
5 |
11 Aug 2023 |
5 |
8 Dec 2023 |
5 |
19 April 2024 |
5 |
16 August 2024 |
5 |
13 December 2024 |
5 |
18 April 2025 |
|||
|
Deadline for Notice of Intent for Re-entry Pathway resubmissions (Friday 5pm AEST) |
6 |
18 Aug 2023 |
6 |
15 Dec 2023 |
6 |
26 Apr 2024 |
6 |
23 Aug 2024 |
6 |
20 Dec 2024 |
6 |
24 Apr 2025 (25 PH) |
|||
|
Deadline for Early Re-entry Pathway resubmissions (Friday 5pm AEST) |
7 |
25 Aug 2023 |
7 |
22 Dec 2023 |
7 |
3 May 2024 |
7 |
30 Aug 2024 |
7 |
3 Jan 2025 (Dept Shutdown 25 Dec – 1 Jan) |
7 |
2 May 2025 |
|||
|
Publication of the updated Agenda on web (Friday) |
8 |
1 Sep 2023 |
8 |
5 Jan 2024 (23 Dec-2 Jan Dept Shutdown) |
8 |
10 May 2024 |
8 |
6 Sept 2024 |
8 |
10 Jan 2025 |
8 |
9 May 2025 |
|||
|
Pre-submission meetings: 8 week cut-off |
9 |
4-8 Sep 2023 |
9 |
8-12 Jan 2024 |
9 |
13-17 May 2024 |
9 |
9-13 Sept 2024 |
9 |
13-17 Jan 2025 |
9 |
12-16 May 2025 |
|||
|
Submission commentaries to Applicants (Wednesday) |
10 |
13 Sept 2023 |
10 |
24 Jan 2024 |
10 |
22 May 2024 |
10 |
18 Sept 2024 |
10 |
22 Jan 2025 |
10 |
21 May 2025 |
|||
|
Applicants’ Pre-Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday); and Consumer comments close (Wednesday)
|
11 |
20 Sep 2023
20 Sep 2023 |
11 |
31 Jan 2024
31 Jan 2024 |
11 |
29 May 2024
29 May 2024 |
11 |
25 Sept 2024
25 Sept 2024 |
11 |
29 Jan 2025
29 Jan 2025 |
11 |
28 May 2025
28 May 2025 |
|||
|
DUSC meeting (Thursday-Friday)
|
12 |
28-29 Sep 2023 |
12 |
8-9 Feb 2024 |
12 |
6-7 June 2024 |
12 |
3-4 Oct 2024 |
12 |
6-7 Feb 2025 |
12 |
5-6 Jun 2025 |
|||
|
ESC meeting (Monday-Tuesday) |
13 |
3-4 Oct 2023 |
13 |
12-13 Feb 2024 |
13 |
11-12 Jun 2024 (10 PH) |
13 |
8-9 Oct 2024 (7 PH) |
13 |
10-11 Feb 2025 |
13 |
10-11 Jun 2025 (9 PH) |
|||
|
Deadline for item delist submissions (Monday 5pm AEST) |
14 |
9 Oct 2023 |
14 |
19 Feb 2024 |
14 |
17 Jun 2024 |
14 |
14 Oct 2024 |
14 |
17 Feb 2025 |
14 |
16 Jun 2025 |
|||
|
Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer comments to Applicants (Wednesday) |
15 |
18 Oct 2023 |
15 |
28 Feb 2024 |
15 |
26 Jun 2024 |
15 |
23 Oct 2024 |
15 |
26 Feb 2025 |
15 |
25 Jun 2025 |
|||
|
Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday) |
16 |
25 Oct 2023 |
16 |
6 Mar 2024 |
16 |
3 Jul 2024 |
16 |
30 Oct 2024 |
16 |
5 Mar 2025 |
16 |
2 Jul 2025 |
|||
|
PBAC MEETING (Wednesday-Friday) |
17 |
1-3 Nov 2023 |
17 |
13-15 Mar 2024 |
17 |
10-12 July 2024 |
17 |
6-8 Nov 2024 |
17 |
12-14 Mar 2025 |
17 |
9-11 Jul 2025 |
|||
|
POST PBAC PROCEDURES: |
18 |
|
18 |
|
18 |
|
18 |
|
18 |
|
18 |
|
|||
|
|
19 |
|
19 |
|
19 |
|
19 |
|
19 |
|
19 |
|
|||
|
Ratified Minutes (positive outcomes) to Applicants (Friday) |
20 |
24 Nov 2023 |
20 |
5 Apr 2024 |
20 |
2 Aug 2024 |
20 |
29 Nov 2024 |
20 |
4 Apr 2025 |
20 |
1 Aug 2025 |
|||
|
Publication of the PBAC December Intracycle Agenda on web (Friday) |
21 |
1 Dec 2023 |
21 |
N/A |
21 |
N/A |
21 |
6 Dec 2024 |
21 |
N/A |
21 |
8 Aug 2025 |
|||
|
PBAC DECEMBER INTRACYCLE MEETING (Wednesday) |
22 |
6 Dec 2023 |
22 |
N/A |
22 |
N/A |
22 |
11 Dec 2024 |
22 |
N/A |
22 |
13 Aug 2025 |
|||
|
Ratified Minutes (all other outcomes) to Applicants (Friday) |
22 |
8 Dec 2023 |
22 |
19 Apr 2024 |
22 |
16 Aug 2024 |
22 |
13 Dec 2024 |
22 |
17 Apr 2025 (18 PH) |
22 |
15 Aug 2025 |
|||
|
Post-PBAC meetings with PBAC Chair (Tue-Wed)
|
23 |
15 Dec 2023 |
23 |
23-24 Apr 2024
|
23 |
20-21 Aug 2024 |
23 |
17-18 Dec 2024
|
23 |
22-23 Apr 2025
|
23 |
19-20 Aug 2025
|
|||
|
Posting of outcomes on website following Applicants’ comments (Friday); and deadline for Notice of Intent for Early Resolution Pathway resubmissions (Friday 5pm AEST) |
23 |
17 Dec 2023 |
23 |
26 Apr 2024 |
23 |
23 Aug 2024 |
23 |
20 Dec 2024 |
23 |
24 Apr 2025 (25 PH) |
23 |
22 Aug 2025 |
|||
|
Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday); and deadline for Early Resolution Pathway resubmissions (Friday 5pm AEST); and
Publication of the PBAC Intracycle Agenda on web (Friday) (except December meeting) |
24 |
22 Dec 2023 |
24 |
3 May 2024 |
24 |
30 Aug 2024 |
24 |
N/A |
24 |
2 May 2025 |
24 |
29 Aug 2025 |
|||
|
PBAC INTRACYCLE MEETING (Friday) (except December meeting); and |
25 |
N/A
|
25 |
10 May 2024 |
25 |
6 Sept 2024 |
25 |
N/A |
25 |
9 May 2025 |
25 |
5 Sept 2025 |
|||
|
PBAC December Intracycle ratified minutes (positive outcomes) to Applicants (Friday) |
25 |
12 January 2024 |
25 |
N/A |
25 |
N/A |
25 |
10 Jan 2025 |
25 |
N/A |
25 |
N/A |
|||
|
|
26 |
|
26 |
|
26 |
|
26 |
|
26 |
|
26 |
|
|||
|
Draft Public Summary Documents (PSDs) to Applicants (Friday); and
PBAC December Intracycle ratified minutes (all other outcomes) to Applicants (Friday) |
27 |
|
27 |
24 May 2024 |
27 |
20 Sept 2024 |
27 |
|
27 |
|
27 |
|
|||
|
|
|||||||||||||||
|
PBAC December Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) |
28 |
23-24 Jan 2024 |
28 |
N/A |
28 |
N/A |
28 |
28-29 Jan 2025 |
28 |
N/A |
28 |
N/A |
|||
|
PBAC Intracycle ratified minutes (positive outcomes) to Applicants (Friday) (except December meeting)
|
28 |
N/A |
28 |
31 May 2024 |
28 |
27 Sept 2024 |
28 |
N/A |
28 |
30 May 2025 |
28 |
26 Sep 2025 |
|||
|
PBAC December Intracycle posting of outcomes on website |
28 |
25 Jan 2024 |
28 |
N/A |
28 |
N/A |
28 |
31 Jan 2025 |
28 |
N/A |
28 |
N/A |
|||
|
|
29 |
N/A |
29 |
|
29 |
|
29 |
|
29 |
|
29 |
|
|||
|
PBAC Intracycle ratified minutes (all other outcomes) to Applicants (Friday) |
30 |
N/A |
30 |
14 Jun 2024 |
30 |
11 Oct 2024 |
30 |
14 Feb 2025 |
30 |
13 Jun 2025 |
30 |
10 Oct 2025 |
|||
|
PBAC Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) (except December meeting) |
31 |
N/A
|
31 |
18-19 Jun 2024 |
31 |
15-16 Oct 2024
|
31 |
N/A
|
31 |
17-18 Jun 2025
|
31 |
14-15 Oct 2025
|
|||
|
Final PSDs to Applicants (Friday) |
31 |
16 Feb 2024 |
31 |
21 Jun 2024
|
31 |
18 Oct 2024
|
31 |
21 Feb 2025
|
31 |
20 Jun 2025
|
31 |
17 Oct 2025
|
|||
|
PBAC Intracycle posting of outcomes on website (except December meeting) |
31 |
N/A |
31 |
21 Jun 2024 |
31 |
18 Oct 2024 |
31 |
N/A |
31 |
20 Jun 2025 |
31 |
17 Oct 2025 |
|||
|
Draft PBAC December Intracycle PSDs to Applicants (Friday) |
32 |
N/A |
32 |
N/A |
32 |
N/A |
32 |
28 Feb 2025 |
32 |
N/A |
32 |
N/A |
|||
|
PSDs published on website (positive & subsequent rejections) (Friday) |
33 |
1 Mar 2024 |
33 |
5 Jul 2024 |
33 |
1 Nov 2024 |
33 |
7 Mar 2025 |
33 |
4 Jul 2025 |
33 |
31 Oct 2025 |
|||
|
|
34 |
|
34 |
|
34 |
|
34 |
|
34 |
|
34 |
|
|||
|
PSDs published on website (1st time rejections & deferrals) (Friday);and |
35 |
15 Mar 2024 |
35 |
19 Jul 2024 |
35 |
15 Nov 2024 |
35 |
21 Mar 2025 |
35 |
11 Jul 2025 |
35 |
14 Nov 2025 |
|||
|
Draft PBAC Intracycle PSDs to Applicants (Friday) (except December meeting) |
35 |
N/A |
35 |
19 Jul 2024 |
35 |
15 Nov 2024 |
35 |
N/A |
35 |
11 Jul 2025 |
35 |
14 Nov 2025 |
|||
|
Final PBAC December Intracycle PSDs to Applicants (Friday) |
36 |
22 Mar 2024 |
36 |
N/A |
36 |
N/A |
36 |
28 Mar 2025 |
36 |
N/A |
36 |
N/A |
|||
|
|
37 |
|
37 |
|
37 |
|
37 |
|
37 |
|
37 |
|
|||
|
PBAC December Intracycle PSDs published on website (positive & subsequent rejections) (Friday) |
38 |
5 Apr 2024 |
38 |
N/A |
38 |
N/A |
38 |
11 Apr 2025 |
38 |
N/A |
38 |
N/A |
|||
|
Final PBAC Intracycle PSDs to Applicants (Friday) (except December meeting) |
39 |
N/A |
39 |
16 Aug 2024 |
39 |
13 Dec 2024 |
39 |
17 Apr 2025 (18 PH) |
39 |
8 Aug 2025 |
39 |
12 Dec 2025 |
|||
|
PBAC December Intracycle PSDs published on website (1st time rejections & deferrals) (Friday) |
40 |
19 Apr 2024 |
40 |
N/A |
40 |
N/A |
40 |
24 Apr 2025 (25 PH) |
40 |
N/A |
40 |
N/A |
|||
|
PBAC Intracycle PSDs published on website (positive & subsequent rejections) (Friday) (except December meeting) |
41 |
N/A |
41 |
30 Aug 2024 |
41 |
20 Dec 2024 (25 Dec –1 Jan Dept shutdown) |
41 |
2 May 2025 |
41 |
22 Aug 2025 |
41 |
19 Dec 2025 (25 Dec – 5 Jan Dept shutdown) |
|||
|
|
42 |
|
42 |
|
42 |
|
42 |
|
42 |
|
42 |
|
|||
|
PBAC Intracycle PSDs published on website (1st time rejections & deferrals) (Friday) (except December meeting) |
43 |
N/A |
43 |
13 Sept 2024 |
43 |
17 Jan 2025 |
43 |
N/A |
43 |
5 Sept 2025 |
43 |
16 Jan 2026 |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
PBAC = Pharmaceutical Benefits Advisory Committee
“responsible persons” = legal wording requirement for terminology – previously known
as sponsors
DUSC = Drug Utilisation Sub Committee
ESC = Economic Sub Committee
ATAGI = Australian Technical Advisory Group on Immunisation
PSDs = Public Summary Documents
TBC = To be Confirmed
* These dates may vary based on the number of submissions received
Accessibility
The documents on this page may not be accessible. If you need help please please contact the HTA Support Unit (htasupportunit@health.gov.au)
Pre-submission meetings
Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.
If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.
Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology. For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.
If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).
